RARE DISEASES A–Z · LETTER L

Lambert-Eaton Syndrome

Lambert-Eaton myasthenic syndrome is a rare autoimmune disorder of the junction between nerve and muscle — but on the opposite side of the junction from myasthenia gravis. The antibodies attack the nerve ending's calcium channels, so the signal to contract is too weak. It matters doubly, because it can be the first sign of a hidden lung cancer.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Lambert-Eaton syndrome is an autoimmune attack on nerve endings that weakens the legs first, with a characteristically dry mouth. About half of cases signal small cell lung cancer. Treating any cancer plus amifampridine tablets improves strength.

The guide

The basics

Normally, a nerve impulse opens calcium channels at the nerve ending, calcium flows in, and packets of acetylcholine are released to trigger the muscle. In Lambert-Eaton syndrome, antibodies block those calcium channels, so too little signal gets through — especially with the first attempts at movement; as impulses repeat, calcium builds up and strength briefly improves, the opposite pattern to myasthenia gravis. Weakness starts in the hips and thighs — climbing stairs and rising from chairs — and may spread to shoulders; eye and swallowing involvement is usually milder than in myasthenia. Reflexes are reduced, and autonomic symptoms are prominent: dry mouth is the commonest, with constipation, erectile dysfunction, and dry eyes. About half of cases are associated with small cell lung cancer — the tumour triggers the immune response — and almost all such patients have smoked.

How it works

The combination of proximal leg weakness, reduced reflexes that perk up after exercise, and dry mouth points to the diagnosis. Blood tests find the calcium-channel (VGCC) antibodies in most patients. Nerve and muscle electrical studies are decisive: the muscle response is small at rest but grows dramatically (often more than doubling) after brief exercise or rapid stimulation — the mirror image of myasthenia. Because of the cancer association, CT or PET-CT of the chest is essential at diagnosis and repeated at intervals for at least two years, since the tumour can appear after the weakness. Where a tumour is found, treating it is part of treating the weakness. Other autoimmune conditions sometimes coexist and are screened for.

Day to day

The first treatment is to find and treat any associated cancer — successful tumour treatment often improves the weakness itself. For the weakness directly, the key medicine is amifampridine (3,4-diaminopyridine), a tablet that prolongs the nerve impulse and lets more calcium in, substantially improving strength in many people; it is the established first-line therapy. Pyridostigmine — the myasthenia standby — helps modestly. When these are insufficient, immunotherapy is added: intravenous immunoglobulin, steroids, and steroid-sparing immunosuppressants; plasma exchange helps some severe cases. Symptomatic measures include saliva substitutes for the dry mouth and standard treatment for constipation and erectile dysfunction. Strength gains are usually meaningful, though treatment is long-term.

When to get help

Neurology follow-up tracks strength, autonomic symptoms, and — crucially — the cancer surveillance schedule, which should not lapse even when you feel well. Report new cough, coughing blood, weight loss, or a new lump promptly, whatever the scan timetable says. Vaccinations and infection treatment matter if immunosuppression is used. Because dry mouth is severe in many people, dental review and saliva substitutes protect teeth. Seek prompt help for rapidly worsening weakness, swallowing difficulty, or breathlessness — although Lambert-Eaton syndrome is usually slower than myasthenia, significant worsening needs same-week assessment, not routine review.

See a doctor promptly if: New coughing of blood, rapidly worsening weakness, or difficulty swallowing or breathing in someone with Lambert-Eaton syndrome needs prompt assessment.

Common questions

Who were Lambert and Eaton?

It is named after Edward Lambert and Lee Eaton, neurologists at the Mayo Clinic who defined the condition's electrical signature in the 1950s. The 'myasthenic' in its full name reflects the resemblance to myasthenia gravis, though the mechanism is the mirror image — pre-junction rather than post-junction.

How is it different from myasthenia gravis?

In myasthenia gravis the attack is on the receiving side (acetylcholine receptors), weakness worsens with use, and the eyes are usually first. In Lambert-Eaton syndrome the attack is on the sending side (calcium channels), the legs are usually first, reflexes are reduced, and strength briefly improves with use.

Why do I need repeated chest scans?

The cancer link is with small cell lung cancer specifically, and it is strong enough that finding it changes care — the tumour often appears within two years of the weakness starting. That is why chest imaging is repeated at intervals even if the first scan is clear.

What is the outlook?

The weakness usually improves substantially with treatment; overall prognosis is dominated by whether a cancer is present and how it responds. When no cancer appears after two years of surveillance, the long-term picture is generally good.

More in Letter L

Related

Sources

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Cancer screening and strength treatment are individual; follow your neurology team's plan.